ESMO 2016: Significant survival gains from neoadjuvant chemo for high-risk soft tissue sarcoma
Neoadjuvant chemotherapy with an anthracycline plus ifosfamide was associated with significant survival gains in patients…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Bone marrow inflammation predicts leukaemia risk
Cancer is generally thought to arise from genetic damage within individual cells, but recent evidence…
Diesel fumes at work cause 130 lung cancer cases every year
Cancer Council is calling for greater cancer awareness in the workplace, following new estimates that…
Immediate breast reconstruction reduces psychological impact of mastectomy
Immediate breast reconstruction (IBR) can avoid some of the psychological effects of undergoing mastectomy for…
HPV vaccine reduces cervical pre-cancers in young US women, new research shows
Every 20 minutes, someone in the United States receives a cancer diagnosis related to human…
ASTRO 16: Cardiac risk a factor when considering hormonal therapy for prostate cancer
Men who received hormonal therapy for prostate cancer had a net harm if they had…
Ovarian removal to prevent ovarian cancer should not be an option for premenopausal women, research finds
The controversial practice of ovary removal in premenopausal women to prevent ovarian cancer should be…
Expectations may not match reality among cancer patients in some early phase clinical trials
In a study of cancer patients considering whether they should participate in phase I clinical…
Blood pressure drug may boost effectiveness of lung cancer treatment
A blood pressure drug may make a type of lung cancer treatment more effective, suggests…
Recycling approved drugs for cancer treatment
Researchers at the University of Bergen have discovered that a drug against kidney cancer possibly…